Increasing evidence indicates that disturbances in brain energy balance, mitochondrial integrity, oxidative regulation, and amino acid metabolism all converge to produce AD pathology, supporting the view that classical markers like amyloid plaques and tau tangles may be downstream consequences of these deeper metabolic failures (Polis and Samson 2019). This evidence concerns the gene MAPT and Alzheimer disease.